文献速递类风湿关节炎

疾病活动度可预测CARMA队列中类风湿关节炎患者心血管事件的发生

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort.
PubMed 文献 · Semin Arthritis Rheum · 2025-09-18

基于西班牙67家医院708例基线无心血管事件的类风湿关节炎患者,前瞻性随访10年,共6608患者年,114例(16.1%)发生心血管事件,线性化事件率为每100患者年1.73例。校正PREVENT-CVD后,中/高疾病活动度(DAS28-ESR>3.2)与心血管风险升高独立相关(HR 1.62;95%CI:1.06-22.47,p=0.03)。

要点

  • 10年随访中114例(16.1%)发生心血管事件,线性化事件率为每100患者年1.73例。
  • 中/高疾病活动度(DAS28-ESR>3.2)者校正后心血管风险升高(HR 1.62;95%CI:1.06-22.47,p=0.03)。
  • PREVENT-CVD评分可用于该人群心血管风险分层。

核心结论

  • 疾病活动度是类风湿关节炎患者心血管结局的关键决定因素。
  • PREVENT-CVD评分是该人群心血管风险分层的有效工具。

研究设计与样本

  • CARMA项目为前瞻性随访10年的研究,2010年7月至2012年1月从西班牙67家医院招募708例类风湿关节炎患者,聚焦招募时无既往心血管事件者。
  • 10年随访时分析心血管事件发生、随访患者年及线性化事件率,并行Cox回归分析(粗分析及校正PREVENT-CVD)。

主要发现

  • 共6608患者年,114例(16.1%)发生心血管事件,线性化事件率为每100患者年1.73例。
  • 发生心血管事件者较未发生者年龄更大(70.7±10.6 vs 62.1±12.8岁,p<0.001),男性比例更高(36.0% vs 20.0%,p<0.001)。
  • 发生心血管事件者高血压(46.5% vs 23.4%,p<0.001)、糖尿病(14% vs 4.9%,p=0.001)、血脂异常(37.7% vs 27.4%,p=0.03)比例更高;基线ESR更高也与未来心血管事件相关。
  • 发生心血管事件者PREVENT-CVD预测10年心血管风险显著更高(18.0% vs 10.3%,p<0.001)。
  • 校正PREVENT-CVD后,较高的粗CRP和尿酸水平与心血管风险升高的关联减弱且不再显著;中/高疾病活动度(DAS28-ESR>3.2)者校正后心血管风险显著更高(HR 1.62;95%CI:1.06-22.47,p=0.03)。

关键数值与推荐

  • 中/高疾病活动度定义为DAS28-ESR>3.2,该组校正后心血管风险HR 1.62(95%CI:1.06-22.47,p=0.03)。
  • PREVENT-CVD评分预测10年心血管风险:发生心血管事件者18.0% vs 未发生者10.3%(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify significant predictors of cardiovascular (CV) events in rheumatoid arthritis (RA) patients from the CARdiovascular in RheuMAtology (CARMA) project, followed prospectively for 10 years. METHODS: Between July 2010 and January 2012, 708 RA patients were recruited from 67 hospitals across Spain. The study focused on patients with no prior CV events at the time of recruitment. At the 10-year follow-up, data on the occurrence of CV events, patient-years of follow-up and linearized event rates were analyzed. Cox regression analyses were conducted, both crude and adjusted for PREVENT-CVD. RESULTS: Over 6608 patient-years, 114 patients (16.1%) experienced CV events, yielding a linearized event rate of 1.73 per 100 patient-years. Patients with CV events were older (70.7± 10.6 vs. 62.1±12.8 years, p<0.001), more frequently male (36.0% vs. 20.0%, p<0.001), and had higher rates of hypertension (46.5% vs. 23.4%, p<0.001), diabetes (14% vs. 4.9%, p=0.001), and dyslipidemia (37.7% vs. 27.4%, p=0.03). Higher baseline erythrocyte sedimentation rate (ESR) was also associated with future CV events. Those who developed CV events had a significantly higher predicted 10-year CV risk using the PREVENT-CVD score (18.0% vs. 10.3%, p<0.001). Cox regression analysis adjusted for PREVENT-CVD showed that although higher crude C-reactive protein and uric acid levels were associated with increased CV risk, after adjustment these associations weakened and became non-significant. However, higher disease activity (DAS28-ESR) was linked to greater CV risk, with moderate/high disease activity (DAS28-ESR>3.2) showing a significantly higher adjusted CV risk (HR 1.62; 95% CI: 1.06-22.47, p=0.03). CONCLUSIONS: Disease activity is a key determinant of CV outcomes in RA patients. The PREVENT-CVD score is an effective tool for CV risk stratification in this population.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Llorca J, Ferraz-Amaro I, Castañeda S, et al. Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort. Semin Arthritis Rheum. 2025. PMID: 41014944. doi:10.1016/j.semarthrit.2025.152833

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。